TruBridge Inc is a provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems... Show more
TruBridge maintains a strong niche in the healthcare RCM sector, targeting small to mid-sized community and rural hospitals that face unique financial pressures. Its end-to-end RCM offerings—spanning patient access, coding, billing, denials management, and cash posting—enable land-and-expand strategies, driving recurring revenue growth. By integrating RCM with electronic health records (EHR) systems, TruBridge delivers operational efficiency and net revenue lifts of 1-3% for clients, securing mid-single-digit market share in its core rural segment.
Competitively, TruBridge differentiates from larger players like Optum and Epic through tailored solutions for underserved markets, emphasizing outsourced staffing, AI-enhanced automation, and offshore capabilities. Ongoing margin expansion and a shift to high-quality recurring revenue underscore its medium-term resilience, though broader competition in healthcare IT demands continued innovation in data analytics and patient financial experience.
The Q1 2026 earnings release, slated for May 6-8, will be pivotal, offering updates on full-year guidance amid a strategic review. Investors will scrutinize progress on RCM bundle adoption and EBITDA margin goals. A potential acquisition closure targeted for July 1 could accelerate service expansion.
Analyst revisions remain influential; recent actions include Cantor Fitzgerald's downgrade to Neutral with a price target hike to $26.25 and BMO Capital's adjustment to $26.25 from $15, signaling improving profitability views despite Hold consensus. Regulatory developments, such as 2026 Medicare policy updates, could catalyze sentiment by heightening outsourcing needs. These events matter as they validate TruBridge's turnaround, potentially shifting consensus toward optimism if execution aligns with expectations.
The RCM industry faces tailwinds from rising automation and AI adoption, projected to cut costs by 25-40% and fuel market growth to $196 billion by 2035. Community hospitals, TruBridge's core clientele, benefit from outsourcing amid reimbursement pressures and workforce shortages.
Macro headwinds include uncertain reimbursement environments and policy shifts in Medicaid/Medicare, alongside inflation-driven cost increases. Interest rate trajectories impact hospital financing, while geopolitical tensions could disrupt supply chains. Positively, rural health funding enhancements in 2026 policies may sustain demand for TruBridge's efficiency tools, directly tying to its business model of optimizing cash flows and reducing denials.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It analyzes vast datasets to spot developing trends, evaluate possible breakouts or reversals, and provide predictions across a wide range of tradable instruments. The engine includes searchable prediction categories, historical performance context, and alert functionality to notify users of shifting patterns. Designed for precision in dynamic markets, it empowers informed decision-making. Explore the Trend Prediction Engine today to enhance your trading strategy.
TruBridge anticipates modest revenue growth in 2026 alongside 200 basis points of adjusted EBITDA margin improvement, driven by RCM scaling and operational efficiencies. Long-term themes include offshore workforce expansion to 60% of clients, AI integration for denials prevention, and sustained recurring revenue focus. Market opportunities lie in rural hospital consolidation and policy-driven outsourcing.
Competitive threats from tech giants persist, but TruBridge's niche positioning mitigates risks. Consensus expects earnings growth of over 40% in 2026, with analysts monitoring capital allocation for M&A or buybacks. Regulatory evolution in reimbursements and technology transitions like RPA (robotic process automation) will shape sustainability, keeping sentiment tied to execution.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a blank check company for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, and reorganization,
Industry ServicestotheHealthIndustry
A.I.dvisor indicates that over the last year, TBRG has been loosely correlated with DOCN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TBRG jumps, then DOCN could also see price increases.
| Ticker / NAME | Correlation To TBRG | 1D Price Change % | ||
|---|---|---|---|---|
| TBRG | 100% | +0.06% | ||
| DOCN - TBRG | 41% Loosely correlated | -4.06% | ||
| GEHC - TBRG | 40% Loosely correlated | -1.54% | ||
| BLZE - TBRG | 40% Loosely correlated | -0.98% | ||
| SHOP - TBRG | 38% Loosely correlated | -0.80% | ||
| HUBS - TBRG | 35% Loosely correlated | -1.83% | ||
More | ||||
| Ticker / NAME | Correlation To TBRG | 1D Price Change % |
|---|---|---|
| TBRG | 100% | +0.06% |
| Services to the Health Industry industry (46 stocks) | 18% Poorly correlated | -2.27% |
| Health Services industry (246 stocks) | 4% Poorly correlated | -1.12% |
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where TBRG declined for three days, in of 258 cases, the price declined further within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 16 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
TBRG broke above its upper Bollinger Band on June 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The 50-day moving average for TBRG moved above the 200-day moving average on May 18, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TBRG advanced for three days, in of 307 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 194 cases where TBRG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TBRG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.191) is normal, around the industry mean (7.367). TBRG has a moderately high P/E Ratio (90.017) as compared to the industry average of (49.962). Projected Growth (PEG Ratio) (0.319) is also within normal values, averaging (1.152). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (1.097) is also within normal values, averaging (5.631).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TBRG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock worse than average.